Related references
Note: Only part of the references are listed.Exogenous Ketone Bodies as Promising Neuroprotective Agents for Developmental Brain Injury
Thomas R. Wood et al.
DEVELOPMENTAL NEUROSCIENCE (2019)
Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges
Rudy J. Castellani et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease
Miho Ota et al.
NEUROSCIENCE LETTERS (2019)
Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
Dariusz Wlodarek
NUTRIENTS (2019)
The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM
Steffen E. Storck et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
A nanoformulation for the preferential accumulation in adult neurogenic niches
Catarina Praca et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice
David Ma et al.
SCIENTIFIC REPORTS (2018)
Epigenetic regulation of the glucose transporter gene Slc2a1 by -hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice
Kosuke Tanegashima et al.
GENES TO CELLS (2017)
Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease
Robert J. Pawlosky et al.
JOURNAL OF NEUROCHEMISTRY (2017)
The Ketone Metabolite β-Hydroxybutyrate Attenuates Oxidative Stress in Spinal Cord Injury by Suppression of Class I Histone Deacetylases
Ganggang Kong et al.
JOURNAL OF NEUROTRAUMA (2017)
Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
Mariline Gameiro et al.
MOLECULES (2017)
On the Metabolism of Exogenous Ketones in Humans
Brianna J. Stubbs et al.
FRONTIERS IN PHYSIOLOGY (2017)
Use of the Ketogenic Diet to Treat Intractable Epilepsy in Mitochondrial Disorders
Eleni Paleologou et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Patrycja Puchalska et al.
CELL METABOLISM (2017)
Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier
Steffen E. Storck et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Ketogenic diets: from cancer to mitochondrial diseases and beyond
Ana F. Branco et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Ketones block amyloid entry and improve cognition in an Alzheimer's model
Jun Xiang Yin et al.
NEUROBIOLOGY OF AGING (2016)
1,25-DIHYDROXYVITAMIN D3 REGULATES EXPRESSION OF LRP1 AND RAGE IN VITRO AND IN VIVO, ENHANCING Aβ1-40 BRAIN-TO-BLOOD EFFLUX AND PERIPHERAL UPTAKE TRANSPORT
Y. -X. Guo et al.
NEUROSCIENCE (2016)
Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats
Csilla Ari et al.
Frontiers in Molecular Neuroscience (2016)
Oleocanthal Enhances Amyloid-β Clearance from the Brains of TgSwDI Mice and in Vitro across a Human Blood-Brain Barrier Model
Hisham Qosa et al.
ACS CHEMICAL NEUROSCIENCE (2015)
In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes
Pietra Candela et al.
BRAIN RESEARCH (2015)
Establishment and Dysfunction of the Blood-Brain Barrier
Zhen Zhao et al.
CELL (2015)
Hyperketonemia (Acetoacetate) Upregulates NADPH Oxidase 4 and Elevates Oxidative Stress, ICAM-1, and Monocyte Adhesivity in Endothelial Cells
Preeti Kanikarla-Marie et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, -amyloid toxicity, and astrocyte function
Leif Hertz et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Meta-analysis of modifiable risk factors for Alzheimer's disease
Wei Xu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1
Anita Ramanathan et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier
Melanie Kuntz et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Ketosis, ketogenic diet and food intake control: a complex relationship
Antonio Paoli et al.
FRONTIERS IN PSYCHOLOGY (2015)
Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease
Fabien Gosselet et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Targeting CNS Transporters for Treatment of Neurodegenerative Diseases
Gabriele Jedlitschky et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester
Sami A. Hashim et al.
JOURNAL OF LIPID RESEARCH (2014)
Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy
Valerie Bomben et al.
NEUROBIOLOGY OF AGING (2014)
A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells
Romeo Cecchelli et al.
PLOS ONE (2014)
Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats
Dominic P. D'Agostino et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
Oxysterols decrease apical-to-basolateral transport of Aβ peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells
Julien Saint-Pol et al.
BRAIN RESEARCH (2013)
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research
Sophie Gillette-Guyonnet et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
Fabien Gosselet et al.
CURRENT ALZHEIMER RESEARCH (2013)
A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease
Yoshihiro Kashiwaya et al.
NEUROBIOLOGY OF AGING (2013)
Accelerated Caco-2 cell permeability model for drug discovery
E. Sevin et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2013)
Nutrition and the Risk of Alzheimer's Disease
Nan Hu et al.
BIOMED RESEARCH INTERNATIONAL (2013)
ALZHEIMER'S DISEASE: INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN (Reprinted from BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol 120, pg 885-890, 1984)
George G. Glenner et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Enhanced Brain Amyloid-beta Clearance by Rifampicin and Caffeine as a Possible Protective Mechanism Against Alzheimer's Disease
Hisham Qosa et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
ABCG2- and ABCG4-Mediated Efflux of Amyloid-β Peptide (1-40) at the Mouse Blood-Brain Barrier
Tuan Minh Do et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation
Olivia S. Anderson et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
The ketogenic diet as a treatment paradigm for diverse neurological disorders
Carl E. Stafstrom et al.
FRONTIERS IN PHARMACOLOGY (2012)
Modelling the Neurovascular Unit and the Blood-Brain Barrier with the Unique Function of Pericytes
Elodie Vandenhaute et al.
CURRENT NEUROVASCULAR RESEARCH (2011)
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice
Markus Krohn et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
Berislav V. Zlokovic
NATURE REVIEWS NEUROSCIENCE (2011)
Brain fuel metabolism, aging, and Alzheimer's disease
Stephen Cunnane et al.
NUTRITION (2011)
Mild experimental ketosis increases brain uptake of 11C-acetoacetate and 18F-fluorodeoxyglucose: a dual-tracer PET imaging study in rats
Fabien Pifferi et al.
NUTRITIONAL NEUROSCIENCE (2011)
MCT Expression and Lactate Influx/Efflux in Tanycytes Involved in Glia-Neuron Metabolic Interaction
Christian Cortes-Campos et al.
PLOS ONE (2011)
Improved Survival, Vascular Differentiation and Wound Healing Potential of Stem Cells Co-Cultured with Endothelial Cells
Dora C. S. Pedroso et al.
PLOS ONE (2011)
Alzheimer's Disease
Dennis J. Selkoe
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Apical-to-Basolateral Transport of Amyloid-beta Peptides through Blood-Brain Barrier Cells is Mediated by the Receptor for Advanced Glycation End-Products and is Restricted by P-Glycoprotein
Pietra Candela et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta
Leon M. Tai et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
Samuel T. Henderson et al.
NUTRITION & METABOLISM (2009)
Issues in Complementary and Alternative Nutrition Treatments
Gerard E. Mullin
NUTRITION IN CLINICAL PRACTICE (2009)
Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-β precursor protein (APP) levels in the aged dog
Christa M. Studzinski et al.
BRAIN RESEARCH (2008)
The role of the cell surface LRP and soluble LRP in blood-brain barrier a clearance in Alzheimer's Disease
R. Deane et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
The ketogenic diet: Uses in epilepsy and other neurologic illnesses
Kristin W. Barañano et al.
Current Treatment Options in Neurology (2008)
B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice
Andrea Fuso et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Modelling of the blood-brain barrier in drug discovery and development
Romeo Cecchelli et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Diet-induced ketosis increases capillary density without altered blood flow in rat brain
Michelle A. Puchowicz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Neuroprotective and disease-modifying effects of the ketogenic diet
Maciej Gasior et al.
BEHAVIOURAL PHARMACOLOGY (2006)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Influence of DL-β-hydroxybutyric acid on cell proliferation and calcium influx
S Cheng et al.
BIOMACROMOLECULES (2005)
Cerebral ketone body metabolism
AAM Morris
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Effects of β-hydroxybutyrate on cognition in memory-impaired adults
MA Reger et al.
NEUROBIOLOGY OF AGING (2004)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Developmental switch in brain nutrient transporter expression in the rat
SJ Vannucci et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Hyperketonemia increases tumor necrosis factor-α secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency
SK Jain et al.
DIABETES (2002)
Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain
RL Leino et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor-associated protein (RAP) - A conserved acidic residue in the complement-type repeats is important for recognition of RAP
OM Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
